| Product Code: ETC5360214 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Gastrointestinal Diseases Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Gastrointestinal Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Gastrointestinal Diseases Market - Industry Life Cycle |
3.4 Israel Gastrointestinal Diseases Market - Porter's Five Forces |
3.5 Israel Gastrointestinal Diseases Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Gastrointestinal Diseases Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Israel Gastrointestinal Diseases Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Gastrointestinal Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in Israel |
4.2.2 Technological advancements in diagnostic and treatment options |
4.2.3 Growing awareness and focus on digestive health in the population |
4.3 Market Restraints |
4.3.1 High treatment costs associated with gastrointestinal diseases |
4.3.2 Limited access to specialized healthcare services in certain regions of Israel |
5 Israel Gastrointestinal Diseases Market Trends |
6 Israel Gastrointestinal Diseases Market Segmentations |
6.1 Israel Gastrointestinal Diseases Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Gastrointestinal Diseases Market Revenues & Volume, By Antacids, 2021-2031F |
6.1.3 Israel Gastrointestinal Diseases Market Revenues & Volume, By Laxatives, 2021-2031F |
6.1.4 Israel Gastrointestinal Diseases Market Revenues & Volume, By Antidiarrheal Agents, 2021-2031F |
6.1.5 Israel Gastrointestinal Diseases Market Revenues & Volume, By Antiemetics, 2021-2031F |
6.1.6 Israel Gastrointestinal Diseases Market Revenues & Volume, By Antiulcer Agents, 2021-2031F |
6.1.7 Israel Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.2 Israel Gastrointestinal Diseases Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Gastrointestinal Diseases Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 Israel Gastrointestinal Diseases Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 Israel Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.3 Israel Gastrointestinal Diseases Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Gastrointestinal Diseases Market Revenues & Volume, By Ulcerative Colitis, 2021-2031F | 6.3.3 Israel Gastrointestinal Diseases Market Revenues & Volume, By Irritable Bowel Syndrome, 2021-2031F |
6.3.4 Israel Gastrointestinal Diseases Market Revenues & Volume, By Crohn Disease, 2021-2031F |
6.3.5 Israel Gastrointestinal Diseases Market Revenues & Volume, By Celiac Disease, 2021-2031F |
6.3.6 Israel Gastrointestinal Diseases Market Revenues & Volume, By Gastroenteritis, 2021-2031F |
6.3.7 Israel Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
7 Israel Gastrointestinal Diseases Market Import-Export Trade Statistics |
7.1 Israel Gastrointestinal Diseases Market Export to Major Countries |
7.2 Israel Gastrointestinal Diseases Market Imports from Major Countries |
8 Israel Gastrointestinal Diseases Market Key Performance Indicators |
8.1 Rate of adoption of advanced diagnostic technologies |
8.2 Percentage of the population undergoing regular screenings for gastrointestinal diseases |
8.3 Number of healthcare facilities offering specialized gastrointestinal care |
8.4 Patient satisfaction scores with gastrointestinal disease treatment services |
8.5 Average wait time for appointments with gastroenterologists |
9 Israel Gastrointestinal Diseases Market - Opportunity Assessment |
9.1 Israel Gastrointestinal Diseases Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Gastrointestinal Diseases Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Israel Gastrointestinal Diseases Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Gastrointestinal Diseases Market - Competitive Landscape |
10.1 Israel Gastrointestinal Diseases Market Revenue Share, By Companies, 2024 |
10.2 Israel Gastrointestinal Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here